Blueberries Medical Corp C.BBM

Alternate Symbol(s): BBRRF

Healthcare Cannabis

Blueberries Medical Corp. is a Canada-based company, which is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. The Company is engaged in the growth, cultivation, and development of medicinal cannabis and related products with operations in Colombia. Its operations are mainly focused on the Bogota Savannah, in central Colombia. The Company is focused on processing and supplying medicinal-grade Cannabis oil extracts, medical flowers, and related products. It is developing and commercializing a range of cannabis-derived ingredients, including high and low tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoids. The Company’s subsidiaries include Blueberries Research Corporation (BRC) and Blueberries SAS (BBSAS). Blueberries SAS is a licensed producer and distributor of medicinal Cannabis and Cannabis-derived products in Colombia.

CSE:BBM - Post by User

Blueberries Medical Corp

<< Previous

Bullboard Posts

Next >>

Post by phoenix_traderon Oct 21, 2020 6:09pm

124 Views

Post# 31759334

New Director makes four insider buys on US market

Date	Issuer	Insider	Transaction	Amount	New Balance
Recent filings
Filed 2020-10-21 06:55 Tx date 2020-10-20	$BBM Blueberries Medical Corp.	Garreton, Facundo 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,995 +57,000 vol $0.035 each	2,645,097
Filed 2020-10-21 06:55 Tx date 2020-10-19	$BBM Blueberries Medical Corp.	Garreton, Facundo 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$455.00 +13,000 vol $0.035 each	2,588,097
Filed 2020-10-21 06:54 Tx date 2020-10-19	$BBM Blueberries Medical Corp.	Garreton, Facundo 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$6,299 +175,000 vol $0.036 each	2,575,097
Filed 2020-10-19 05:29 Tx date 2020-10-16	$BBM Blueberries Medical Corp.	Garreton, Facundo 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$7.20 +200 vol $0.036 each	2,400,097